Clinical pearls and therapeutic challenges in connective tissue disease

Dermatologic Therapy

Volumn 14, Issue 2, 2001, Pages 126-133

  Dean, Raymond J ^a,b   Fivenson, David P ^a  

^a HENRY FORD HEALTH SYSTEM   (United States)

^b HENRY FORD HOSPITAL   (United States)

Author keywords

Calcinosis cutis; Leg ulcers; Steroid sparing agents; Therapy; Wound healing

Indexed keywords

AZATHIOPRINE; CHLOROQUINE; CLOFAZIMINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DAPSONE; ETRETINATE; GOLD; HYDROXYCHLOROQUINE; ISOTRETINOIN; MEPACRINE; METHOTREXATE; PREDNISONE; STEROID; SUNSCREEN; THALIDOMIDE;

AUTOIMMUNE DISEASE; CONNECTIVE TISSUE DISEASE; DERMATOMYOSITIS; DISCOID LUPUS ERYTHEMATOSUS; LEG ULCER; PRURITUS; PYODERMA GANGRENOSUM; RAYNAUD PHENOMENON; REVIEW; SCLERODERMA; SKIN CALCIFICATION; SKIN DISEASE; SKIN ULCER; WOUND CARE; WOUND HEALING;

EID: 0035018945     PISSN: 13960296     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1529-8019.2001.014002126.x     Document Type: Review

References (7)

1. Eyelid dermatitis to red face syndrome to cure: Clinical experience in 100 cases
2. Efficacy and safety of naltrexone, an oral opiate receptor antagonist, in the treatment of pruritus in internal and dermatological diseases
3. Regression of calcinosis during diltiazem treatment in juvenile dermatomyositis
4. Diltiazem induces remission of calcinosis in scleroderma
5. A case of calcinosis universalis successfully treated with low-dose warfarin
6. Calcinosis cutis in juvenile dermatomyositis responsive to aluminum hydroxide treatment
7. Calcinosis universalis complicating juvenile dermatomyositis: Resolution during probenecid therapy